FLEXION THERAPEUTICS INC's ticker is FLXN and the CUSIP is 33938J106.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $0 | -100.0% | 5,949 | +891.5% | 0.00% | -100.0% |
Q4 2019 | $12,000 | -74.5% | 600 | -82.9% | 0.00% | -75.0% |
Q3 2019 | $47,000 | -29.9% | 3,500 | -36.4% | 0.00% | -33.3% |
Q2 2019 | $67,000 | +3250.0% | 5,500 | +2650.0% | 0.01% | – |
Q1 2019 | $2,000 | -93.5% | 200 | -94.6% | 0.00% | -100.0% |
Q4 2018 | $31,000 | +158.3% | 3,700 | -75.7% | 0.00% | +100.0% |
Q2 2018 | $12,000 | -97.4% | 15,200 | -65.4% | 0.00% | -97.5% |
Q1 2018 | $458,000 | +31.6% | 43,948 | +2.5% | 0.04% | +185.7% |
Q4 2017 | $348,000 | +62.6% | 42,895 | -20.4% | 0.01% | +75.0% |
Q3 2017 | $214,000 | +30.5% | 53,900 | -10.2% | 0.01% | +33.3% |
Q2 2017 | $164,000 | -41.8% | 60,025 | -7.3% | 0.01% | -50.0% |
Q1 2017 | $282,000 | +340.6% | 64,744 | +39.2% | 0.01% | +500.0% |
Q4 2016 | $64,000 | -78.6% | 46,500 | +94.6% | 0.00% | -85.7% |
Q3 2016 | $299,000 | +33.5% | 23,892 | +51.3% | 0.01% | +27.3% |
Q2 2016 | $224,000 | +206.8% | 15,795 | +68.0% | 0.01% | +120.0% |
Q1 2016 | $73,000 | -35.4% | 9,400 | -1.1% | 0.01% | -16.7% |
Q4 2015 | $113,000 | – | 9,500 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 3,842,578 | $40,001,000 | 7.32% |
MILLER VALUE PARTNERS, LLC | 5,274,439 | $54,907,000 | 1.97% |
Mesirow Financial Investment Management, Inc. | 32,371 | $337,000 | 1.44% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,068,580 | $11,124,000 | 1.25% |
Clearline Capital LP | 399,159 | $4,155,000 | 1.09% |
CLOUGH CAPITAL PARTNERS L P | 1,246,150 | $12,972,000 | 0.93% |
Novo Holdings A/S | 1,403,370 | $14,609,000 | 0.72% |
SNOW CAPITAL MANAGEMENT LP | 303,265 | $3,157,000 | 0.63% |
AMERICAN FINANCIAL GROUP INC | 317,700 | $3,308,000 | 0.46% |
Granahan Investment Management | 1,257,690 | $13,093,000 | 0.44% |